TG
Tong Ren Tang Technologies Co. Ltd.
TGRNF · OTC
$0.40 +0.00% (+$0.00)
Market Cap ¥4.40B
P/E Ratio 11.41x
Div. Yield 4.63%
ROE 5.30%
Bulios Fair Price
$0.28
29.9% downside
Current Price
$0.4
Undervalued Fair Value Overvalued
According to Bulios Fair Price, TGRNF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
100 /100
Cheap P/FCF 3.05x
P/S 0.70x
P/B 0.60x
Growth
40 /100
Stable Rev. growth 1.77%
FCF growth 36.70%
Book val. growth 4.25%
Profitability
69 /100
Strong Net margin 6.11%
Op. margin 12.43%
FCF margin 22.89%
Quality
27 /100
Poor ROE 5.30%
ROA 2.81%
Asset turnover 0.46x
Debt
100 /100
Low Current ratio 5.72x
Int. coverage 13.52x
Net debt/EBITDA -3.44x
Stability
93 /100
Stable Rev. volatility 13.66%
EPS volatility 13.49%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TGRNF
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Chun You Zhang
Employees
3,951
Headquarters
Beijing
Upcoming events
19 MAR
Earnings
Upcoming earnings report